Brown Brothers Harriman & CO Eli Lilly & CO Transaction History

Brown Brothers Harriman & CO

$14 Billion
Q3 2024

A detailed history of Brown Brothers Harriman & CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 21,668 shares of LLY stock, worth $17.1 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

21,668

Previous 18,660 16.12%

Holding current value

$17.1 Million

Previous $16.9 Million 13.63%

% of portfolio

0.14%

Previous 0.13%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $2.32 Million - $2.89 Million	3,008 Added 16.12%	21,668 $19.2 Million
Q2 2024 Aug 09, 2024	BUY	$724.87 - $909.04 $1.88 Million - $2.36 Million	2,599 Added 16.18%	18,660 $16.9 Million
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $599,898 - $802,579	-1,013 Reduced 5.93%	16,061 $12.5 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $42,015 - $49,530	80 Added 0.47%	17,074 $9.95 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $339,500 - $468,053	781 Added 4.82%	16,994 $9.13 Million
Q2 2023 Aug 07, 2023	BUY	$350.74 - $468.98 $67,692 - $90,513	193 Added 1.2%	16,213 $7.6 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $31,373 - $36,846	-101 Reduced 0.63%	16,020 $5.5 Million
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $98,072 - $114,274	-305 Reduced 1.86%	16,121 $5.9 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $77,381 - $88,184	-261 Reduced 1.56%	16,426 $5.31 Million
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $987,819 - $1.16 Million	-3,544 Reduced 17.52%	16,687 $5.41 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $1.01 Million - $1.25 Million	4,286 Added 26.88%	20,231 $5.79 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $156,270 - $193,932	695 Added 4.56%	15,945 $4.4 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $10,193 - $12,544	46 Added 0.3%	15,250 $3.52 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $543,997 - $703,656	-3,013 Reduced 16.54%	15,204 $3.49 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $47,817 - $61,901	-291 Reduced 1.57%	18,217 $3.4 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $32,615 - $43,157	-250 Reduced 1.33%	18,508 $3.13 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $10,235 - $11,839	-70 Reduced 0.37%	18,758 $2.78 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $30,558 - $36,776	-224 Reduced 1.18%	18,828 $3.09 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $9,881 - $12,230	83 Added 0.44%	19,052 $2.64 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $355,081 - $439,800	3,321 Added 21.22%	18,969 $2.49 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $81,907 - $89,094	767 Added 5.15%	15,648 $1.75 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $83,535 - $97,507	754 Added 5.34%	14,881 $1.65 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $112,200 - $132,068	-1,008 Reduced 6.66%	14,127 $1.83 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $66,081 - $74,031	624 Added 4.3%	15,135 $1.75 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $42,414 - $53,011	494 Added 3.52%	14,511 $1.56 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $109,310 - $125,454	-1,444 Reduced 9.34%	14,017 $1.2 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $265,671 - $313,608	-3,580 Reduced 18.8%	15,461 $1.2 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $428,792 - $459,928	5,233 Added 37.9%	19,041 $1.61 Million
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $41,849 - $46,448	-543 Reduced 3.78%	13,808 $1.18 Million
Q2 2017 Aug 14, 2017	BUY	N/A	14,351	14,351 $1.18 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.

Account

Brown Brothers Harriman & CO Eli Lilly & CO Transaction History